We also reported recently that IFN-α and 5-FU combination therapy synergistically inhibited tumor angiogenesis in vivo and their effects correlated with regulation of VEGF and angiopoietins (Angs) [16]. The gene discussed is VEGFA; the disease is neoplasm.